Osteosarcoma Recurrent Clinical Trials

8 clinical trials for Osteosarcoma Recurrent across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). — RECRUITING · PHASE1
• Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma — RECRUITING · PHASE1
• DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma — RECRUITING · PHASE1
• Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma — ACTIVE_NOT_RECRUITING · PHASE1
• Olaparib With Ceralasertib in Recurrent Osteosarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer — COMPLETED
• Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma — COMPLETED

Refine this search